Sealantium Medical

Sealantium Medical Overview

Sealantium Medical is a biosurgery company focused on the development of proprietary next generation tissue sealants and hemostatic agents for patients undergoing surgery. The company's flagship product is the sFilm-FS™, which comprises a biodegradable and biocompatible, non-permeable polymeric film containing Fibrin Sealant. This polymeric film uniquely enables sealing capabilities alongside accelerating fluid coagulation and site adhesion. As a result of this novel mechanism of action, substantially less Fibrin Sealant is needed lowering costs and accelerating speed of sealing (2min) for improved performance. Successful preclinical data has demonstrated efficacy and usability of the sFilm-FS. Promising early clinical results show safety and a faster performance in controlling liver bleeding during surgery than the market leading product.

Cumulative Funding Raised Over Time ($)

Latest News

Jun 22, 2023 · sealantium-med.com

growth-positive

Sealantium Medical announces completion of its phase I/II clinical study - Sealantium

Sealantium Medical has completed the enrollment of 32 patients for its Phase I/II clinical study of its flagship product, sFilm-FS, in the EU and the U.S. The study is comparing the safety and efficacy of sFilm-FS against TachoSil, the market-leading product for controlling liver bleeding. Interim data suggests that sFilm-FS is safe and effective, with final data expected in 3Q23. Pivotal Phase III studies are expected to start in 4Q23.

Investment

Nov 14, 2017 · www.einpresswire.com

growth-positive

Sealantium Medical retains Biotech Alliances International to Lead Series B $10 Million Capital Raise

Biotech Alliances International will serve as the lead investment banker to Sealantium Medical for its $10 million Series B capital raise. The funding will be used to complete Phase III study, manufacturing scale-up, and US/EU regulatory approval for Sealantium Medicals novel product, sFilm-FS™. The product is a bio-compatible bio-absorbable, polymeric film embedded with lyophilized human fibrinogen and human thrombin, offering a state-of-the-art solution to unmet surgical needs. Sealantium Medical has already completed safety and efficacy studies in rodents and pigs and has received the Seal of Excellence from the European Commission. Human studies will begin after FDA approval. Biotech Alliances International will introduce Sealantium Medical to international investors at a healthcare conference in San Francisco.

Investment

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Amal 11, Rosh Haayin, Israel

Photos & Videos

2 item(s)

Sealantium Medical Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info